Fidele Ntie‐Kang

This study evaluates the safety and immunogenicity of a novel onchocerciasis vaccine candidate, OvMANE1, in mice, showing increased antibody levels and cellular immune responses.

This paper introduces a microplate reader-based method to detect HIV latency reversal in J-Lat cells without flow cytometry, identifying new latency-reversing agents.

The paper predicts the immunogenicity and safety of two vaccine candidates against onchocerciasis using immunoinformatics, identifying their potential to induce protective immune responses.